Xconomy Recognizes Novoron as San Diego Life Science Startup to Watch in 2016

SAN DIEGO, February 9, 2016 – As 2016 gains momentum, Xconomy reporter, Bruce Bigelow, takes a look at the life science landscape and recognizes a dozen innovative biotech startups to watch in 2016. 

Novoron, recently awarded a NIH Grant to evaluate new treatments for multiple sclerosis, was selected as a company to watch for it’s innovation in development of novel therapeutics for disorders of the central nervous system.  

Lauren Anderson

Founder | CEO

Previous
Previous

Novoron Recognized as Innovative San Diego Biotech

Next
Next

Interview: Remyelination in MS with Novoron Bioscience